The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases Conference

cited authors

  • Sperduto, Paul W; Jiang, Wen; Brown, Paul D; Braunstein, Steve; Sneed, Penny; Wattson, Daniel A; Shih, Helen A; Bangdiwala, Ananta; Shanley, Ryan; Lockney, Natalie A; Beal, Kathryn; Lou, Emil; Amatruda, Thomas; Sperduto, William A; Kirkpatrick, John P; Yeh, Norman; Gaspar, Laurie E; Molitoris, Jason K; Masucci, Laura; Roberge, David; Yu, James; Chiang, Veronica; Mehta, Minesh

fiu authors

publication date

  • August 1, 2017

keywords

  • CANCER
  • IMPROVED SURVIVAL
  • IPILIMUMAB
  • Life Sciences & Biomedicine
  • PEMBROLIZUMAB
  • RADIATION-THERAPY
  • Radiology, Nuclear Medicine & Medical Imaging
  • STEREOTACTIC RADIOSURGERY
  • Science & Technology

Digital Object Identifier (DOI)

start page

  • 1069

volume

  • 98